Similarly, in Phase 2, RF-positive patients showed a trend toward lower flare-free population rates compared with RF-negative patients; however, the difference was not statistically significant (Fig. 2 E).
← all excerpts
Stepwise dose reduction and discontinuation of bDMARD in rheumatoid arthritis: a prospective cohort study of flare-free population, flares, and predictive markers.
1
—
—